The tentative performance result of 10 pharmaceutical companies on the third quarter of the year

Published: 2014-11-04 15:45:10

Updated: 2014-11-04 15:45:10

It was observed that the major listed pharmaceutical companies in Korea showed poor sales performance on the third quarter of the year.

According to the third quarter tentative performance result of the 10 pharmaceutical companies listed in KOSPI by 31 October, they only showed single-digit growth with 4.5% in sales, and double-digit declines with 275% and 36.4% in the sales profit and the net...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.